WALDWICK, N.J., Jan. 17 /PRNewswire-FirstCall/ -- NEXCORE Technology, Inc, a world-class original equipment manufacturer (OEM) of medical devices, has licensed all the intellectual property rights for the development of a major advance in fluid management during endoscopic surgery. The new system provides significantly greater control over the inflow/outflow of fluids during a procedure.
The patents on the system are held by Drs. Atul and Alka Kumar. Dr. Atul Kumar, a pioneer in hysteroscopic surgery, is scientific director of the Women's Health Center in Jaipur, India. Dr. Alka Kumar is the director of the Women's Health Center.
NEXCORE is designing and developing the new system and will organize testing and FDA approval.
According to Milton Frank, President and CEO of NEXCORE, "The new system maintains a constant preset cavity pressure during operations regardless of how the flow rate of the irrigational fluid is varied allowing for optimal visualization. The system measures the intravasation rate and total fluid intravasation."
Intravasation is fluid that is absorbed into the blood vessels during a procedure, which can cause severe injury, or even death, if not properly monitored.
The new system can be used in any endoscopic surgery. It distends the
body tissue cavity by utilizing continuous flow irrigation. The new
invention increases surgical efficiency, effectiveness and safety by
maintaining a constant pressure on the mechanical distension of the cavity
and increases and maintains visibility for the surgeon.
Features unique to the new system include:
-- The fluid pressure is independent of the flow rate and the desired
cavity pressure and distention can be maintained for an indefinite
time. A clinical study published in 2004 reported that endometrial
resections were performed on 539 women using the new system without any
complications because of the system's predictably stable mechanical
-- Predictably constant and clear visualization is present throughout the
procedure. Only negligible or minimal fluid turbulence is present
inside the cavity even at relatively high flow rates.
-- The real-time rate of intravasation is known throughout the procedure
thwarting fluid intravasation, or fluid overload, a dangerous
complication in procedures such as trans urethral surgery and
hysteroscopic surgery. In current systems, the fluid absorbed in the
patient's body is determined by subtracting the waste fluid from the
sterile fluid. In the new system, the instantaneous introduction of
fluid into the blood stream can be determined without any fluid sensors
and the surgeon can act within seconds.
-- It is possible to safely, easily and quickly switch between two
different types of irrigation fluid.
NEXCORE plans to introduce the system in late 2008.
NEXCORE Technology is a world-class OEM medical device manufacturer
specializing in complex diagnostic and therapeutic systems. It produces
some of the industries most innovative products for numerous large and
sophisticated medical device manufacturers, taking the specifications from
concept through design and manufacturing to after-market services. For
additional company information: http://www.nexcoretech.com
Contact: Judd Cohen
|SOURCE NEXCORE Technology, Inc|
Copyright©2008 PR Newswire.
All rights reserved